Action Red Light Holland (QB) - TRUFF

Red Light Holland Corporation (QB) (TRUFF) Action

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Dernier

0,02149

( 5,24% )

Prix Achat

0,0126

Prix Vente

0,0297

Volume échangé

66 908

0,0201 Fourchette du Jour 0,0249

0,005 Plage de 52 semaines 0,048

Cap du marché

13,198M

Clôture Veille

0,02042

Ouverture

0,0249

Dernière Transaction

25000

0.02149

Dernière heure de transaction

Volume financier

US$ 1 442

VWAP

0,021551

Volume moyen (3 m)

US$ 405 424

Actions en circulation

614 124 756

Rendement du Dividende (LTM)

Ratio Cours sur Bénéfices

-2,07

Bénéfice par action (BPA)

-0,01

Chiffre d'affairess (LTM)

4,17M

Bénéfice net (LTM)

-4,97M

Red Light Holland Corp. engages in the production, growth, and sale of functional mushrooms and mushroom home grow kits to the recreational market in North America and Europe. The company is also involved in the selection, distribution, and export of truffles, cannabidiol products, cannabis seeds, h... Red Light Holland Corp. engages in the production, growth, and sale of functional mushrooms and mushroom home grow kits to the recreational market in North America and Europe. The company is also involved in the selection, distribution, and export of truffles, cannabidiol products, cannabis seeds, headshop products, growshop goods, cannabis bake house muffins, cookies, and cakes. It sells its products under the iMicrodose, Maka, Happy Caps, and Mistercap’s brands through brick-and-mortar SmartShops, as well as through online stores. Red Light Holland Corp. is based in Toronto, Canada. Show more

Secteur

Healthcare

Industrie

Pharmaceuticals

Site Web

redlight.co

Siège social

Toronto, Canada

Fondé

Red Light Holland Corporation (QB) est coté dans le secteur Healthcare de la OTC Markets avec le ticker TRUFF. Le dernier cours de clôture d'Red Light Holland (QB) était de US$0,02. Au cours de la dernière année, les actions de Red Light Holland (QB) ont été négociées dans une fourchette de prix de US$ 0,005 à US$ 0,048.

Red Light Holland (QB) compte actuellement 614 124 756 actions en circulation. La capitalisation boursière d'Red Light Holland (QB) est de US$13,20 million. Red Light Holland (QB) a un ratio cours/bénéfice (ratio PE) de -2.07.

Red Light Holland Reports Positive Preclinical Study Results for Coca in Weight Gain Prevention Post GLP-1 from Magdalena Biosciences, the Joint Venture Held Through Its Wholly Owned Subsidiary, Filament Health

Whole leaf coca extract under evaluation is Magdalena's drug candidate for post GLP-1 weight loss managementToronto, Ontario--(Newsfile Corp...

Red Light Holland's Wholly Owned Subsidiary, Filament Health, Signs Agreement to Supply PEX010 Botanical Psilocybin Drug Candidate for Study at GHU Paris Psychiatrie & Neurosciences in France

Toronto, Ontario--(Newsfile Corp. - June 8, 2026) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland", "Red...

Red Light Holland Announces Filament Health's PEX010 Drug Candidate, the Standardized and Patented Natural Psilocybin Trusted Across 80+ Studies Globally, Selected by UCSF for Study Probing Preclinical Alzheimer's Markers

Filament Health will supply its standardized, patented PEX010 botanical psilocybin drug candidate, produced using proprietary extraction and...

Red Light Holland Expands New Zealand Partnership with Allu Therapeutics to Advance Access to Filament Health's GMP-Compliant PEX010 Botanical Psilocybin Drug Candidate

The expanded agreement adds Filament Health, a wholly owned subsidiary of Red Light Holland, as a supplying affiliate and introduces a...

Red Light Holland's Wholly Owned Subsidiary, Filament Health, Advances PEX010 Clinical Footprint with New Canadian Academic Studies in Palliative Care, Bipolar II Depression, and Healthy Adult Mechanism Research

Toronto, Ontario--(Newsfile Corp. - May 14, 2026) - Red Light Holland Corp. (CSE: TRIP) (OTCQB: TRUFF) (FSE: 4YX) ("Red Light" or the "Company...

Red Light Holland Announces Shareholder Approval of Name Change and Announces Voting Results from 2026 Annual General and Special Meeting of Shareholders

Toronto, Ontario--(Newsfile Corp. - May 13, 2026) - Red Light Holland Corp. (CSE: TRIP) (OTCQB: TRUFF) (FSE: 4YX) ("Red Light Holland" or the...

Red Light Holland Highlights Publication of Randomized Clinical Trial Showing a Single Dose of Psilocybin Reduced Cocaine Use, with Filament Health Holding the Exclusive License to the Data and Intellectual Property

Peer-reviewed results published yesterday (May 7, 2026) in JAMA Network Open demonstrate that a single dose of psilocybin meaningfully reduced...

Red Light Holland's Wholly Owned Subsidiary, Filament Health, Expands Distribution of PEX010 Across Canadian and U.S. Research Institutions

Toronto, Ontario--(Newsfile Corp. - May 7, 2026) - Red Light Holland Corp. (CSE: TRIP) (OTCQB: TRUFF) (FSE: 4YX) ("Red Light" or the "Company") is...

Red Light Holland Announces Intention to Rebrand

New name and branding to be announced in the coming weeks, better aligned with the Company's scientific mandate and all business segmentsName...

Red Light Holland Completes Acquisition of Filament Health, Creating a Global Leader in Psychedelic Drug Development, Commercialization and Distribution

Establishes a vertically integrated platform spanning pharmaceutical-grade botanical drug development and...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	-0.00011	-0.509259259259	0.0216	0.0249	0.0176	55165	0.02035218	CS
4	-0.00681	-24.0636042403	0.0283	0.0328	0.0172	278597	0.02393568	CS
12	0.00219	11.3471502591	0.0193	0.0429	0.0163	340154	0.02715328	CS
26	0.00649	43.2666666667	0.015	0.0429	0.005	238449	0.02294285	CS
52	-0.00185	-7.92630676949	0.02334	0.048	0.005	239153	0.02428342	CS
156	-0.04051	-65.3387096774	0.062	0.07	0.005	152066	0.03126378	CS
260	-0.25201	-92.1425959781	0.2735	0.32695	0.005	160316	0.07630451	CS

TRUFF - Frequently Asked Questions (FAQ)

What is the current Red Light Holland Corporation (QB) share price?

The current share price of Red Light Holland Corporation (QB) is US$ 0,02149

How many Red Light Holland Corporation (QB) shares are in issue?

Red Light Holland Corporation (QB) has 614 124 756 shares in issue

What is the market cap of Red Light Holland Corporation (QB)?

The market capitalisation of Red Light Holland Corporation (QB) is USD 13,2M

What is the 1 year trading range for Red Light Holland Corporation (QB) share price?

Red Light Holland Corporation (QB) has traded in the range of US$ 0,005 to US$ 0,048 during the past year

What is the PE ratio of Red Light Holland Corporation (QB)?

The price to earnings ratio of Red Light Holland Corporation (QB) is -2,07

What is the cash to sales ratio of Red Light Holland Corporation (QB)?

The cash to sales ratio of Red Light Holland Corporation (QB) is 3,68

What is the registered address of Red Light Holland Corporation (QB)?

The registered address for Red Light Holland Corporation (QB) is 1 Adelaide Street East, Toronto, Ontario, M5C 2V9

What is the Red Light Holland Corporation (QB) website address?

The website address for Red Light Holland Corporation (QB) is redlight.co

Which industry sector does Red Light Holland Corporation (QB) operate in?

Red Light Holland Corporation (QB) operates in the Pharmaceuticals sector

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Red Light Holland Corporation (QB) (TRUFF)

Red Light Holland Corporation (QB) (TRUFF) Action

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

À propos de Red Light Holland Corporation (QB)

TRUFF Dernières nouvelles

Red Light Holland Reports Positive Preclinical Study Results for Coca in Weight Gain Prevention Post GLP-1 from Magdalena Biosciences, the Joint Venture Held Through Its Wholly Owned Subsidiary, Filament Health

Red Light Holland's Wholly Owned Subsidiary, Filament Health, Signs Agreement to Supply PEX010 Botanical Psilocybin Drug Candidate for Study at GHU Paris Psychiatrie & Neurosciences in France

Red Light Holland Announces Filament Health's PEX010 Drug Candidate, the Standardized and Patented Natural Psilocybin Trusted Across 80+ Studies Globally, Selected by UCSF for Study Probing Preclinical Alzheimer's Markers

Red Light Holland Expands New Zealand Partnership with Allu Therapeutics to Advance Access to Filament Health's GMP-Compliant PEX010 Botanical Psilocybin Drug Candidate

Red Light Holland's Wholly Owned Subsidiary, Filament Health, Advances PEX010 Clinical Footprint with New Canadian Academic Studies in Palliative Care, Bipolar II Depression, and Healthy Adult Mechanism Research

Red Light Holland Announces Shareholder Approval of Name Change and Announces Voting Results from 2026 Annual General and Special Meeting of Shareholders

Red Light Holland Highlights Publication of Randomized Clinical Trial Showing a Single Dose of Psilocybin Reduced Cocaine Use, with Filament Health Holding the Exclusive License to the Data and Intellectual Property

Red Light Holland's Wholly Owned Subsidiary, Filament Health, Expands Distribution of PEX010 Across Canadian and U.S. Research Institutions

Red Light Holland Announces Intention to Rebrand

Red Light Holland Completes Acquisition of Filament Health, Creating a Global Leader in Psychedelic Drug Development, Commercialization and Distribution

Kala Bio Celebrates Trump Executive Order as Game-Changer for Psychedelic Medicine

Red Light Holland Engages Kala Bio’s Researgency.AI Platform to Support Clinical Development of Filament’s Patented PEX010 Botanical Psilocybin Drug Candidate

TRUFF - Frequently Asked Questions (FAQ)

TRUFF Transactions

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Red Light Holland Corporation (QB) (TRUFF)

Red Light Holland Corporation (QB) (TRUFF) Action

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

À propos de Red Light Holland Corporation (QB)

TRUFF Dernières nouvelles

Red Light Holland Reports Positive Preclinical Study Results for Coca in Weight Gain Prevention Post GLP-1 from Magdalena Biosciences, the Joint Venture Held Through Its Wholly Owned Subsidiary, Filament Health

Red Light Holland's Wholly Owned Subsidiary, Filament Health, Signs Agreement to Supply PEX010 Botanical Psilocybin Drug Candidate for Study at GHU Paris Psychiatrie & Neurosciences in France

Red Light Holland Announces Filament Health's PEX010 Drug Candidate, the Standardized and Patented Natural Psilocybin Trusted Across 80+ Studies Globally, Selected by UCSF for Study Probing Preclinical Alzheimer's Markers

Red Light Holland Expands New Zealand Partnership with Allu Therapeutics to Advance Access to Filament Health's GMP-Compliant PEX010 Botanical Psilocybin Drug Candidate

Red Light Holland's Wholly Owned Subsidiary, Filament Health, Advances PEX010 Clinical Footprint with New Canadian Academic Studies in Palliative Care, Bipolar II Depression, and Healthy Adult Mechanism Research

Red Light Holland Announces Shareholder Approval of Name Change and Announces Voting Results from 2026 Annual General and Special Meeting of Shareholders

Red Light Holland Highlights Publication of Randomized Clinical Trial Showing a Single Dose of Psilocybin Reduced Cocaine Use, with Filament Health Holding the Exclusive License to the Data and Intellectual Property

Red Light Holland's Wholly Owned Subsidiary, Filament Health, Expands Distribution of PEX010 Across Canadian and U.S. Research Institutions

Red Light Holland Announces Intention to Rebrand

Red Light Holland Completes Acquisition of Filament Health, Creating a Global Leader in Psychedelic Drug Development, Commercialization and Distribution

Kala Bio Celebrates Trump Executive Order as Game-Changer for Psychedelic Medicine

Red Light Holland Engages Kala Bio’s Researgency.AI Platform to Support Clinical Development of Filament’s Patented PEX010 Botanical Psilocybin Drug Candidate

TRUFF - Frequently Asked Questions (FAQ)

TRUFF Transactions

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Pourquoi rejoindre ADVFN?

Tout ce dont les traders professionnels ont besoin.

Supprimer les publicités